CanSino: Ad5-nCoV-IH
Vaccine Type: Non Replicating Viral Vector
Vaccine Trial & Approval Tracker
-
Phase 1
-
Phase 2
-
Phase 3
-
Approved
This vaccine has reached Phase 3 trials.
About Trial Phases
Phase 1:
0
Trials
There are no trials for this phase.
Phase 2:
0
Trials
There are no trials for this phase.
Approvals
This vaccine is not yet approved.
Registered Trials
-
NCT05204589
Phase 3
China
Total Enrollment: 10,420
Official Trial Registration:
-
NCT05124561
Phase 3
Total Enrollment: 13,000
Official Trial Registration:
-
NCT05169008
Phase 3
Chile, Mexico
Total Enrollment: 2,000
Official Trial Registration:
